Medication info
Credible Tablets 10/20 mg (Ezetimibe, Rosuvastatin Calcium)

Credible Tablets 10/20 mg (Ezetimibe, Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceuticals Co., Ltd.
Appearance
White to almost white round film-coated tablet
Packaging
30 tablets (10 tablets/PTP packaging X3), 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201601209 · Approved 2016.02.29 · Insurance code 645305460

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is taken once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients who are taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Hanlim Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease
View approved original text

This medication is used to improve blood lipid levels in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial forms, as well as mixed dyslipidemia. Specifically, it lowers levels of total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol, while increasing levels of HDL-cholesterol, thereby reducing the risk of atherosclerotic vascular diseases. This medication is administered as an adjunct to appropriate dietary measures when other non-pharmacological therapies do not provide sufficient effect. Furthermore, it is important to confirm the presence of secondary causes like diabetes or hypothyroidism before starting treatment and treat them if necessary. By checking and managing lipid levels, the patient's condition can be closely monitored, and assistance can be provided to quickly test and initiate treatment in cases of acute cardiovascular events. Therefore, this medication is safely and effectively used to improve hypercholesterolemia and dyslipidemia.

How to take

Adult dose

This medicine is taken once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased up to a maximum of 10/20 mg once daily. Patients who are taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause a rare serious side effect called rhabdomyolysis, which can lead to severe muscle problems. In particular, if there are risk factors such as severe infections, hypotension, major surgery, trauma, severe metabolic disorders, or uncontrolled seizures, the use of this medication should be temporarily stopped or discontinued. Patients with allergic reactions to the active ingredient or components of this medication should not take it, nor should it be administered to patients with severe liver dysfunction or muscle diseases. Additionally, it is contraindicated in patients with severely impaired renal function, women who are pregnant or may become pregnant, and women who are breastfeeding. Caution should be exercised when administering this medication to patients at high risk of developing myopathy or rhabdomyolysis, such as those with renal impairment, hypothyroidism, a history of genetic muscle disorders, a history of myotoxicity from statins or fibrates, alcoholics, and Asian patients. This medication may cause liver dysfunction, so liver function tests should be conducted before and during treatment, and treatment should be halted if liver enzyme levels significantly increase. If symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, fever, etc. occur during treatment, the physician should be informed immediately, and in severe cases, the medication should be discontinued. This medication can interact with other drugs, so patients must inform their physician or pharmacist, especially if they are taking anticoagulants, fibrates, certain antibiotics, antifungals, or immunosuppressants. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should employ appropriate contraception while on treatment. This medication requires special attention in children and the elderly, and safety in pediatric populations has not been adequately established. In cases of overdose, there is no specific antidote, so appropriate treatment and supportive therapy should be administered based on symptoms, and liver function and muscle enzyme levels should be regularly monitored. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Pharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial swelling, strange sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, burning sensation of the skin, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid ptosis, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasm, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, depression, sleep disorders, headache, dizziness, increased ALT, increased AST, chest pain, cough, myalgia, increased CK, constipation, asthenia, arthralgia, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, chest pain, dizziness, fatigue, headache, abdominal pain, diarrhea, pharyngitis, sinusitis, upper respiratory tract infection, arthralgia, low back pain, myalgia, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, increased creatine phosphokinase, myopathy, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, paresthesia, cholelithiasis, cholecystitis, fatigue, chest pain, chest discomfort, edema, asthenia, systemic edema, headache, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastric area, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, rash, itching, upper respiratory tract infection, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. The storage temperature should be maintained between 1 degree and 30 degrees Celsius. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White to almost white round film-coated tablet

Package unit

30 tablets (10 tablets/PTP packaging X3), 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.